Heart Vascular Function and Thyroid Hormone Receptors

心脏血管功能和甲状腺激素受体

• 批准号: 8398969
• 负责人: Wolfgang H Dillmann
• 金额: --
• 依托单位: VA SAN DIEGO HEALTHCARE SYSTEM
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-07-01 至 2015-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8398969
• 关键词: Angiogenic Peptides; Blood Pressure; Blood Vessels; Blood capillaries; Blood flow; Cardiac; Cardiac Myocytes; Cardiovascular system; Clinical; Consumption; Coronary; Coronary artery; Data; Endothelial Cells; Endothelium; Future; Genes; Healthcare; Heart; Heart Hypertrophy; Heart Rate; Hyperthyroidism; Infarction; Injury; Ischemia; Kidney; Knowledge; Lead; Link; Mediating; Medical; Molecular; Morbidity - disease rate; Mus; Myocardial; Myocardial Infarction; Myocardial Ischemia; Myocardial perfusion; Myocardium; Organ; Outcome; Oxygen Consumption; Perfusion; Peripheral; Peripheral Resistance; Physiological; Protein Isoforms; Receptor Signaling; Relaxation; Renal Blood Flow; Reperfusion Injury; Reperfusion Therapy; Research Proposals; Simulate; Skeletal Muscle; Stem cells; TNFRSF11B gene; Testing; Thyroid Hormone Receptor; Transgenic Mice; Translations; Tube; Vascular Endothelial Cell; Vascular resistance; Vasomotor; Veterans; angiogenesis; base; capillary; comparative; coronary perfusion; density; femoral artery; hemodynamics; improved; in vivo; loss of function; migration; mortality; myocardial infarct sizing; novel strategies; patient population; pre-clinical research; prevent; public health relevance; receptor expression; research study; success

DESCRIPTION (provided by applicant): Ischemic heart disease continues to be a significant medical problem and approaches other than coronary artery revascularization have had no long term success to improve myocardial perfusion. Hyperthyroidism increases coronary perfusion and enhances cardiac capillary density but these beneficial vascular effects are accompanied by undesirable cardiac changes like increases in heart rate and cardiac O2 consumption. It is currently unclear if increasing the expression of thyroid hormone receptor (TR) isoforms TR1 or TR2 only in vascular endothelial cells (ECs) can result in beneficial vascular effects in the absence of undesirable cardiac or systemic changes. In addition the detailed mechanisms by which TR isoforms exert their effects in ECs are largely unexplored. We generated mice with EC specific expression or deletion of TR1 and TR2 to explore effects on vascular function with a focus on coronary perfusion and cardiac capillary density. In Aim I we explore if changes in TR1 or TR2 expression in ECs effects vascular function especially coronary perfusion and coronary artery contraction and relaxation. In addition we identify mechanisms which mediate these changes. Preliminary results show that increased expression of TR11 in ECs leads to a marked increase in coronary perfusion in the absence of undesirable effects like increases in heart rate, oxygen consumption, or a significant decrease in systemic vascular resistance. In Aim II we determine the effects of EC-based TR1 and TR2 expression or deletion on cardiac capillary density. Our preliminary data show that changes of TR2 expression in ECs exerts selective effects markedly increasing cardiac capillary density with no effect by TR1. In Aim III we determine if increasing TR1 or TR2 expression in ECs and restoring ischemia reperfusion (I/R) mediated decreases in TR levels ameliorates I/R mediated cardiac injury. Preliminary results show that exposing hearts or ECs to I/R like conditions significantly lowers EC TR levels. In addition we find that increasing TR expression in ECs ameliorates I/R mediated injury and decreases infarct size under in vivo conditions. The studies may lead to novel approaches to improve coronary perfusion and increase substrate exchange by increasing cardiac capillary density in the absence of undesirable effects. In addition new knowledge related to TR action in ECs will be obtained. POTENTIAL IMPACT ON VETERANS HEALTH CARE: Ischemic heart disease significantly contributes to morbidity and mortality in the veteran patient population. The "preclinical" research of this proposal demonstrates significant improvement in cardiac microcirculatory function and decreased myocardial infarct size by expression of thyroid hormone receptors in vascular endothelial cells. These findings may lead to clinical translation in future approaches.

描述（由申请人提供）： 缺血性心脏病仍然是一个重要的医学问题，除了冠状动脉血运重建之外，其他方法在改善心肌灌注方面尚未取得长期成功。甲状腺功能亢进会增加冠状动脉灌注并增强心脏毛细血管密度，但这些有益的血管效应会伴随着不良的心脏变化，例如心率和心脏耗氧量增加。目前尚不清楚仅在血管内皮细胞 (EC) 中增加甲状腺激素受体 (TR) 同工型 TR1 或 TR2 的表达是否可以在没有不良心脏或全身变化的情况下产生有益的血管效应。此外，TR 亚型在 EC 中发挥作用的详细机制在很大程度上尚未被探索。我们培育了 EC 特异性表达或 TR1 和 TR2 缺失的小鼠，以探索对血管功能的影响，重点是冠状动脉灌注和心脏毛细血管密度。在目标 I 中，我们探讨 EC 中 TR1 或 TR2 表达的变化是否会影响血管功能，特别是冠状动脉灌注和冠状动脉收缩和舒张。此外，我们还确定了调节这些变化的机制。初步结果表明，EC 中 TR11 表达的增加会导致冠状动脉灌注显着增加，而不会产生不良影响，例如心率增加、耗氧量增加或全身血管阻力显着降低。在目标 II 中，我们确定基于 EC 的 TR1 和 TR2 表达或缺失对心脏毛细血管密度的影响。我们的初步数据表明，EC 中 TR2 表达的变化发挥选择性作用，显着增加心脏毛细血管密度，而 TR1 没有影响。在目标 III 中，我们确定增加 EC 中 TR1 或 TR2 的表达以及恢复缺血再灌注 (I/R) 介导的 TR 水平降低是否可以改善 I/R 介导的心脏损伤。初步结果表明，将心脏或 EC 暴露于类似 I/R 的条件下会显着降低 EC TR 水平。此外，我们发现增加 EC 中的 TR 表达可改善 I/R 介导的损伤并减少体内条件下的梗塞面积。这些研究可能会带来新的方法，通过增加心脏毛细血管密度来改善冠状动脉灌注和增加底物交换，而不会产生不良影响。此外，还将获得与 EC 中 TR 作用相关的新知识。对退伍军人医疗保健的潜在影响：缺血性心脏病对退伍军人患者群体的发病率和死亡率有显着影响。该提案的“临床前”研究表明，通过血管内皮细胞中甲状腺激素受体的表达，可显着改善心脏微循环功能并减少心肌梗塞面积。这些发现可能会导致未来方法的临床转化。